New pill could help hospitalized ulcerative colitis patients avoid surgery
NCT ID NCT07502339
First seen Apr 02, 2026 · Last updated Jun 14, 2026 · Updated 13 times
Summary
This study tests whether the oral medication upadacitinib can safely treat adults hospitalized with acute severe ulcerative colitis and potentially reduce the need for steroids or surgery. About 50 participants will take upadacitinib daily while in the hospital and be monitored for up to a year. The results will be compared to past patients who received standard treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UC - ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSF Medical Center
San Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.